PHVS (NASDAQ) reports director/entity 10b5-1 sales on April 22–30, 2026

Rhea-AI Filing Summary

PHVS filed a Form 144 reporting sales of Common Stock under prearranged 10b5-1 plans. The filing lists broker-dealer Morgan Stanley Smith Barney LLC and shows multiple 10b5-1 sales by Anne Simonne J. Lesage and Graymatters Consulting on 04/22/2026, 04/23/2026, 04/29/2026, and 04/30/2026

Examples shown include 21,700 shares sold by Lesage on 04/30/2026 for $656,550.86 and 19,200 shares sold by Graymatters Consulting on 04/30/2026 for $580,909.44. Shares outstanding are listed as 65,210,590 shares as of 06/25/2026.

Insights

Securities Counsel

Form 144 discloses Rule 10b5-1 sales by covered persons through a registered broker.

The filing lists multiple 10b5-1 transactions by Anne Simonne J. Lesage and Graymatters Consulting, with specific trade dates and per-trade proceeds. The sales are reported via Morgan Stanley Smith Barney LLC as the broker-dealer.

These entries are routine compliance disclosures required when holders sell restricted or control securities; cash-flow treatment and any holding-period qualifications are not detailed in the excerpt.

Key Figures

Shares outstanding: 65,210,590 shares Sale — Lesage: 21,700 shares Sale — Graymatters Consulting: 19,200 shares +3 more

6 metrics

Shares outstanding 65,210,590 shares as of 06/25/2026

Sale — Lesage 21,700 shares sold 04/30/2026 for $656,550.86

Sale — Graymatters Consulting 19,200 shares sold 04/30/2026 for $580,909.44

Sale example — Lesage 7,500 shares sold 04/22/2026 for $225,361.90

Sale example — Graymatters Consulting 7,000 shares sold 04/22/2026 for $210,357.70

Broker-dealer listed Morgan Stanley Smith Barney LLC registered broker on the filing

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares financial

"Common | 12/31/2016 | Founders Shares"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

What does PHVS's Form 144 show about insider sales?

The Form 144 reports multiple Rule 10b5-1 sales of PHVS common stock by two holders. It lists trade dates (April 22–30, 2026) and per-trade proceeds such as $656,550.86 for 21,700 shares on 04/30/2026.

Who acted as the broker for the reported transactions in PHVS Form 144?

The filing names Morgan Stanley Smith Barney LLC as the broker-dealer. The broker information appears on the disclosure line together with the issuer and address details in the excerpt.

How many shares outstanding does PHVS report in this excerpt?

The excerpt lists 65,210,590 shares outstanding as of 06/25/2026. That figure appears on the issuer/securities information line in the provided content.

Were the sales in PHVS Form 144 executed under trading plans?

Yes. The transactions are labeled as 10b5-1 Sales, indicating they were executed under prearranged Rule 10b5-1 plans, as shown in each trade line in the excerpt.

Does the Form 144 excerpt disclose total proceeds or aggregate shares sold?

The excerpt provides per-trade proceeds and share counts for individual dates (e.g., 21,700 shares for $656,550.86), but it does not present an aggregate total of all sales in the provided lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/25/2026 - 04:24 PM Accepted by SEC EDGAR 06/25/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2300	76567.00	65210590	06/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2016	Founders Shares	Issuer			2300	12/31/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	21700	656550.86
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	19200	580909.44
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111280.46
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111229.40
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7500	225361.90
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7000	210357.70

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)